{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:58:59Z","timestamp":1790452739605,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020439","name":"Jiangsu Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinthera.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:52:41Z","timestamp":1790139161000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy, Safety, and Economic Evaluation of Originator Versus Generic Moxifloxacin Hydrochloride Injection in the Treatment of Community-Acquired Pneumonia Under China's National Centralized Drug Procurement Policy: A Retrospective Study"],"prefix":"10.1016","author":[{"given":"Xiangyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuecheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongling","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinthera.2026.08.018_bib0001","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00735-2022","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"61","author":"Martin-Loeches","year":"2023","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.clinthera.2026.08.018_bib0002","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.clinthera.2026.08.018_bib0003","first-page":"117","article-title":"Guideline for primary care of adult community acquired pneumonia (2018)","volume":"18","year":"2019","journal-title":"Chin J Gen Pract"},{"issue":"10225","key":"10.1016\/j.clinthera.2026.08.018_bib0004","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"The GBD Chronic Kidney Disease","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0005","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2147\/IDR.S251564","article-title":"Etiology of community-acquired pneumonia requiring hospital admission in adults with and without cancers: a single-center retrospective study in China","volume":"13","author":"Wang","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.clinthera.2026.08.018_bib0006","first-page":"625","article-title":"Community-acquired pneumonia in adults: rapid evidence review","volume":"105","author":"Womack","year":"2022","journal-title":"Am Fam Phys"},{"issue":"10","key":"10.1016\/j.clinthera.2026.08.018_bib0007","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/j.1528-1167.2007.01272.x","article-title":"Generic products of antiepileptic drugs (AEDs): Is it an issue?","volume":"48","author":"Bialer","year":"2007","journal-title":"Epilepsia"},{"issue":"16","key":"10.1016\/j.clinthera.2026.08.018_bib0008","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.121.057727","article-title":"Price and quality in the generic pharmaceutical market","volume":"145","author":"Teasdale","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.clinthera.2026.08.018_bib0009","first-page":"31","article-title":"Pharmacoeconomic evaluation of volume-based procured, non-procured, and imported moxifloxacin injections in the treatment of pulmonary infection","volume":"17","author":"Zhang","year":"2022","journal-title":"China J Pharm Econom"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0010","first-page":"844","article-title":"Guidance for clinical trials of anti-bacterial drugs","volume":"30","year":"2014","journal-title":"Chin J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.clinthera.2026.08.018_bib0011","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical Practice Guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0012","series-title":"China Guidelines for Pharmacoeconomic Evaluations 2020","author":"Liu","year":"2020"},{"issue":"3","key":"10.1016\/j.clinthera.2026.08.018_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MCP.0000000000000052","article-title":"Community-acquired pneumonia","volume":"20","author":"Remington","year":"2014","journal-title":"Curr Opin Pulmonary Med"},{"issue":"2","key":"10.1016\/j.clinthera.2026.08.018_bib0014","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.21037\/apm-20-2612","article-title":"Moxifloxacin is a safe and effective candidate agent for tuberculosis treatment: a meta-analysis of randomized controlled trials","volume":"10","author":"Sun","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"25","key":"10.1016\/j.clinthera.2026.08.018_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020648","article-title":"Meta-analysis on effectiveness and safety of moxifloxacin in treatment of multidrug resistant tuberculosis in adults","volume":"99","author":"Guan","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0016","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1471-2466-14-105","article-title":"Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI)","volume":"14","author":"Kuzman","year":"2014","journal-title":"BMC Pulmonary Med"},{"issue":"22","key":"10.1016\/j.clinthera.2026.08.018_bib0017","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033896","article-title":"Comprehensive clinical evaluation of moxifloxacin: a retrospective study","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.clinthera.2026.08.018_bib0018","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1378\/chest.125.3.953","article-title":"Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis","volume":"125","author":"Wilson","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0019","first-page":"1","article-title":"Comprehensive clinical evaluation of moxifloxacin injections from different manufacturers in treating community-acquired pneumonia in the context of the Centralized Procurement Policy","author":"Guo","year":"2025","journal-title":"Chin J Hosp Pharm"},{"issue":"2","key":"10.1016\/j.clinthera.2026.08.018_bib0020","first-page":"200","article-title":"Comparison of efficacy, safety and economics of bid-winning and original Moxifloxacin hydrochloride tablets in the treatment of outpatient community-acquired pneumonia","volume":"34","author":"Pang","year":"2023","journal-title":"China Pharm"},{"issue":"5","key":"10.1016\/j.clinthera.2026.08.018_bib0021","first-page":"17","article-title":"Analysis of the policy effects of the national centralized quantity-based procurement of antibacterial drugs","volume":"42","author":"Li","year":"2023","journal-title":"Chin Health Econ"},{"issue":"9","key":"10.1016\/j.clinthera.2026.08.018_bib0022","first-page":"13","article-title":"Analysis of the impact of centralized volume-based procurement policy on drug utilization and expenditure","volume":"41","author":"Lin","year":"2022","journal-title":"Chin Health Econ"},{"issue":"2","key":"10.1016\/j.clinthera.2026.08.018_bib0023","first-page":"52","article-title":"Systematic review of the impact of centralized drug procurement policy on drug prices and utilization","volume":"16","author":"Sun","year":"2023","journal-title":"Chin J Health Policy"},{"issue":"3","key":"10.1016\/j.clinthera.2026.08.018_bib0024","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hpm.3429","article-title":"The impact of National Centralised Drug Procurement policy on the use of policy-related original and generic drugs in China","volume":"37","author":"Yang","year":"2022","journal-title":"Int J Health Plan Manag"},{"key":"10.1016\/j.clinthera.2026.08.018_bib0025","article-title":"National centralized drug procurement and health care expenditure of households-micro-evidence from CFPS","volume":"12","author":"Li","year":"2024","journal-title":"Front Public Health"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826003346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826003346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:25:23Z","timestamp":1790450723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826003346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0149291826003346"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.08.018","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, Safety, and Economic Evaluation of Originator Versus Generic Moxifloxacin Hydrochloride Injection in the Treatment of Community-Acquired Pneumonia Under China's National Centralized Drug Procurement Policy: A Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}